Search Results - "Ng, Cheng Han"

Research Trends on Literature Reviews in Scopus Journals by Authors from Indonesia, Japan, South Korea, Vietnam, Singapore, and Malaysia: A Bibliometric Analysis from 2003 to 2022.

Authors: Putera, Prakoso Bhairawa Gustina, Amelya

Source: Asian Journal of Innovation & Policy. 2023, Vol. 12 Issue 3, p304-322. 19p.

Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.

Authors: Ng, Cheng Han Lim, Wen Hui Chin, Yip Han et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2022, Vol. 56 Issue 4, p570-579. 10p. 3 Diagrams, 1 Chart.

The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis.

Authors: Danpanichkul, Pojsakorn Ng, Cheng Han Muthiah, Mark D. et al.

Source: Alimentary Pharmacology & Therapeutics. Nov2023, Vol. 58 Issue 10, p1062-1074. 13p.

Securing Transplanted Meniscal Allografts Using Bone Plugs Results in Lower Risks of Graft Failure and Reoperations: A Meta-analysis.

Authors: Ow, Zachariah Gene Wing Cheong, Chin Kai Hai, Hao Han et al.

Source: American Journal of Sports Medicine. Dec2022, Vol. 50 Issue 14, p4008-4018.

Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis.

Authors: Ng, Cheng Han Muthiah, Mark D. Xiao, Jieling et al.

Source: Alimentary Pharmacology & Therapeutics. May2022, Vol. 55 Issue 9, p1076-1087. 12p. 4 Diagrams, 2 Charts.

Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis.

Authors: Kohira, Toshikazu Oeda, Satoshi Eto, Erina et al.

Source: Scientific Reports. 8/30/2025, Vol. 15 Issue 1, p1-11. 11p.

Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis.

Authors: Lim, Wen Hui Tay, Phoebe Ng, Cheng Han et al.

Source: Alimentary Pharmacology & Therapeutics. Mar2024, Vol. 59 Issue 6, p730-741. 12p.

A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectives.

Authors: Lim, Wen Hui Chan, Kai En Ng, Cheng Han et al.

Source: PLoS ONE. 12/30/2022, Vol. 17 Issue 12, p1-14. 14p.

Meta‐analysis: Prevalence of significant or advanced fibrosis in adults with alpha‐1‐antitrypsin deficiency.

Authors: Huang, Daniel Q. Chan, Kai En Tan, Caitlyn et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2023, Vol. 58 Issue 2, p152-158. 7p. 1 Diagram, 1 Chart, 2 Graphs.

Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

Authors: Koh, Jeffery Wei Heng Ng, Cheng Han Tay, Sen Hee

Source: Lupus. Dec2020, Vol. 29 Issue 14, p1845-1853. 9p. 1 Diagram, 3 Graphs.

The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome.

Authors: Fu, Clarissa Elysia Yong, Jie Ning Ng, Cheng Han et al.

Source: Alimentary Pharmacology & Therapeutics. May2023, Vol. 57 Issue 9, p979-987. 9p. 2 Diagrams, 4 Charts, 1 Graph.

The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021.

Authors: Tham, Ethan Kai Jun Tan, Darren Jun Hao Danpanichkul, Pojsakorn et al.

Source: Liver International. Mar2025, Vol. 45 Issue 3, p1-12. 12p.

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.

Authors: Tan, Darren Jun Hao Tamaki, Nobuharu Kim, Beom Kyung et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2025, Vol. 61 Issue 2, p278-285. 8p.

Alcohol‐Attributable Cancer: Update From the Global Burden of Disease 2021 Study.

Authors: Danpanichkul, Pojsakorn Pang, Yanfang Díaz, Luis Antonio et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2025, Vol. 62 Issue 1, p33-47. 15p.

Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019.

Authors: Danpanichkul, Pojsakorn Chen, Vincent L. Chaiyakunapruk, Nathorn et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2024, Vol. 60 Issue 3, p340-349. 10p.

The perspectives of health professionals and patients on racism in healthcare: A qualitative systematic review.

Authors: Sim, Wilson Lim, Wen Hui Ng, Cheng Han et al.

Source: PLoS ONE. 8/31/2021, Vol. 16 Issue 8, p1-15. 15p.

Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling.

Authors: Tan, Eunice X. Huang, Daniel Q. Yee, Natasha Tang Sook et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2024, Vol. 59 Issue 8, p984-992. 9p.

The unspoken reality of gender bias in surgery: A qualitative systematic review.

Authors: Lim, Wen Hui Wong, Chloe Jain, Sneha Rajiv et al.

Source: PLoS ONE. 2/2/2021, Vol. 16 Issue 2, p1-18. 18p.

Editorial: clinical outcomes in lean NAFLD—the devil is in the details.

Authors: Tan, Eunice X. X. Muthiah, Mark Dhinesh Ng, Cheng Han et al.

Source: Alimentary Pharmacology & Therapeutics. May2023, Vol. 57 Issue 9, p1040-1041. 2p.

Clinical features and outcomes of NAFLD-related hepatocellular carcinoma - Authors' reply.

Authors: Tan, Darren Jun Hao Ng, Cheng Han Muthiah, Mark D et al.

Source: Lancet Oncology. Jun2022, Vol. 23 Issue 6, pe244-e244. 1p.